Moreover, AS-IV engages the NF-κB/NLRP3 signaling pathway to elevate endogenous klotho protein expression, thus offering a protective shield for DN-affected glomerular podocytes in hyperglycemic conditions (47). The gene discussed is NLRP3; the disease is liver dysplastic nodule.